Polymethacrylate microparticles gel for topical drug delivery.

Pharmaceutical Research
Hagar Ibrahim Labouta, Labiba K El-Khordagui

Abstract

Evaluating the potentials of particulate delivery systems in topical drug delivery. Polymethacrylate microparticles (MPs) incorporating verapamil hydrochloride (VRP) as a model hydrophilic drug with potential topical clinical uses, using Eudragit RS100 and Eudragit L100 were prepared for the formulation of a composite topical gel. The effect of initial drug loading, polymer composition, particularly the proportion of Eudragit L100 as an interacting polymer component and the HLB of the dispersing agent on MPs characteristics was investigated. A test MPs formulation was incorporated in gel and evaluated for drug release and human skin permeation. MPs showed high % incorporation efficiency and % yield. Composition of the hybrid polymer matrix was a main determinant of MPs characteristics, particularly drug release. Factors known to influence drug release such as MPs size and high drug solubility were outweighed by strong VRP-Eudragit L100 interaction. The developed MPs gel showed controlled VRP release and reduced skin retention compared to a free drug gel. Topical drug delivery and skin retention could be modulated using particulate delivery systems. From a practical standpoint, the VRP gel developed may offer advantage in a rang...Continue Reading

References

Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·P Costa, J M Sousa Lobo
Feb 9, 2002·Dermatology : International Journal for Clinical and Investigative Dermatology·F D'AndreaA Baroni
Jun 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·S A Wissing, R H Müller
May 20, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·D D VermaA Fahr
Sep 29, 2004·Biochemical and Biophysical Research Communications·Cai-Hong ZhengWen-Quan Liang
Nov 4, 2004·Drug Development and Industrial Pharmacy·Ramprakash Govindarajan, Mangal S Nagarsenker
Jan 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sergio FreitasBruno Gander
Oct 10, 2006·AAPS PharmSciTech·Ahmed S ZidanMuhammad J Habib
Jul 27, 2007·Journal of Microencapsulation·Eman H NafeaNawal M Khalafallah
Sep 14, 2007·International Journal of Impotence Research·B Fallon
Dec 21, 2007·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Gerald B KastingTycho J Speaker
Apr 2, 2008·Biological & Pharmaceutical Bulletin·Deependra SinghShailendra Saraf
May 10, 2008·Journal of Microencapsulation·Azita HaddadiEffat Sadat Farboud
Jul 30, 2008·Skin Pharmacology and Physiology·J LademannA Patzelt
Aug 19, 2008·International Journal of Pharmaceutics·Ming LiDenis Poncelet
Nov 8, 2008·Drug Development and Industrial Pharmacy·Heba S BarakatNawal M Khalafallah
Jul 9, 2009·Biotechnology Advances·Mi Lan KangHan Sang Yoo
Aug 1, 2009·Journal of Pharmaceutical Sciences·Hagar I LaboutaGhaly M Ghaly
Sep 15, 2009·International Journal of Pharmaceutics·N S BerchaneM J Andrews
Sep 22, 2009·International Journal of Pharmaceutics·Yan Sim LeeSean P Rigby
Mar 23, 2010·European Journal of Medicinal Chemistry·Jie ZhangLangchong He

❮ Previous
Next ❯

Citations

Jul 10, 2012·Expert Opinion on Drug Delivery·Ali Demir Sezer, Erdal Cevher
Feb 9, 2012·International Journal of Pharmaceutics·C Loira-PastorizaP Maincent
May 13, 2020·Current Drug Delivery·Sunil Kumar JainKuldeep Rajpoot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Anda Vintiloiu, Jean-Christophe Leroux
Advanced Drug Delivery Reviews
W E Hennink, C F van Nostrum
Expert Opinion on Drug Delivery
Sudaxshina Murdan
© 2021 Meta ULC. All rights reserved